Emicizumab and Recombinant FVIIa for Safe Surgical Removal of a Massive Pseudotumor in Severe Hemophilia A with Inhibitor.
- DOI
- 10.1055/a-2924-5496
- Published
- 2026 Aug 4
- Container
- Seminars in thrombosis and hemostasis
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1055/a-2924-5496,
title = {Emicizumab and Recombinant FVIIa for Safe Surgical Removal of a Massive Pseudotumor in Severe Hemophilia A with Inhibitor.},
author = {Burge C and Franks D and Pow R and Luk P and Matthews S and Khoo L},
year = {2026},
journal = {Seminars in thrombosis and hemostasis},
doi = {10.1055/a-2924-5496},
url = {https://doi.org/10.1055/a-2924-5496}
}RIS
TY - JOUR TI - Emicizumab and Recombinant FVIIa for Safe Surgical Removal of a Massive Pseudotumor in Severe Hemophilia A with Inhibitor. AU - Burge C AU - Franks D AU - Pow R AU - Luk P AU - Matthews S AU - Khoo L PY - 2026 JO - Seminars in thrombosis and hemostasis DO - 10.1055/a-2924-5496 UR - https://doi.org/10.1055/a-2924-5496 ER -
APA
C, B., D, F., R, P., P, L., S, M., & L, K. (2026). Emicizumab and Recombinant FVIIa for Safe Surgical Removal of a Massive Pseudotumor in Severe Hemophilia A with Inhibitor.. Seminars in thrombosis and hemostasis. https://doi.org/10.1055/a-2924-5496
Source records
- pubmed · retrieved 2026-11-10T09:26:40.553Z